|
Market Closed -
Nasdaq
01:30:00 13/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 507.00 USD | -0.60% |
|
+0.70% | +11.83% |
| Market Cap | 13TCr 12TCr 11TCr 9.73TCr 18TCr 12,28400Cr 18TCr 1,28900Cr 50TCr 6,33900Cr 48TCr 47TCr 20,39900Cr | P/E 2026 * |
44.8x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 12TCr 11TCr 10TCr 9.31TCr 18TCr 11,75400Cr 18TCr 1,23300Cr 48TCr 6,06600Cr 46TCr 45TCr 19,51900Cr | EV / Sales 2026 * |
9.27x | EV / Sales 2027 * | 8.15x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
London S.E.
| 0QZU | Delayed | |
|
Xetra
| VX1 | Delayed | |
|
Tradegate
| VX1 | Real-time | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.60% | ||
| 1 week | +0.70% | ||
| Current month | -3.02% | ||
| 1 month | -1.64% | ||
| 3 months | +4.45% | ||
| 6 months | +16.21% | ||
| Current year | +11.83% |
| 1 week | 498.9 |  | 514.9 |
| 1 month | 496.15 | | 529.89 |
| Current year | 412.27 | | 560.25 |
| 1 year | 403.16 | | 560.25 |
| 3 years | 341.9 | | 560.25 |
| 5 years | 177.71 | | 560.25 |
| 10 years | 71.46 | | 560.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/04/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 10/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 01/01/1998 |
Jeffrey Leiden
CHM | Chairman | 70 | 01/05/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 18/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/08/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 27/08/26 | Don | Director | -6,000 | 0.0024% | ||
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.60% | +0.70% | +24.33% | +37.77% | 13TCr | |
| +0.28% | +3.46% | +41.89% | +93.71% | 1,05400Cr | |
| +0.88% | +4.27% | +38.28% | +68.70% | 64TCr | |
| +1.68% | +5.78% | +21.96% | +89.56% | 50TCr | |
| -0.10% | +4.24% | +69.15% | +40.41% | 36TCr | |
| +0.61% | +3.18% | +24.05% | +42.46% | 34TCr | |
| +0.72% | +2.99% | +14.29% | +34.71% | 27TCr | |
| +0.23% | +2.23% | -5.91% | +8.15% | 25TCr | |
| +0.65% | +3.62% | +43.93% | +46.50% | 23TCr | |
| -0.49% | +4.01% | +28.38% | +95.97% | 19TCr | |
| Average | +0.33% | +2.90% | +30.03% | +55.79% | 39.51TCr | |
| Weighted average by Cap. | +0.38% | +3.11% | +33.74% | +66.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33TCr 1.19TCr 1.11TCr 1TCr 1.89TCr 1,26800Cr 1.91TCr 13TCr 5.21TCr 65TCr 4.98TCr 4.87TCr 2,10500Cr | 1.46TCr 1.31TCr 1.22TCr 1.1TCr 2.08TCr 1,39400Cr 2.1TCr 15TCr 5.73TCr 72TCr 5.48TCr 5.36TCr 2,31500Cr |
| Net income | 294.71Cr 263.82Cr 245.94Cr 223.07Cr 420.74Cr 28TCr 423.38Cr 2.96TCr 1.16TCr 15TCr 1.11TCr 1.08TCr 47TCr | 480.9Cr 430.5Cr 401.32Cr 364.01Cr 686.55Cr 46TCr 690.86Cr 4.82TCr 1.89TCr 24TCr 1.81TCr 1.77TCr 76TCr |
| Net Debt | -554.44Cr -496.34Cr -462.69Cr -419.68Cr -791.55Cr -53TCr -796.51Cr -5.56TCr -2.18TCr -27TCr -2.08TCr -2.04TCr -88TCr | -958.18Cr -857.77Cr -799.62Cr -725.28Cr -1.37TCr -92TCr -1.38TCr -9.61TCr -3.76TCr -47TCr -3.6TCr -3.52TCr -1,52100Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $507.00 | -0.60% | 9,52,749 |
| 09/26/09 | $510.08 | +1.36% | 14,80,861 |
| 08/26/08 | $503.25 | -0.47% | 14,87,972 |
| 07/26/07 | $505.64 | +0.66% | 8,06,840 |
| 06/26/06 | $502.31 | -0.24% | 7,75,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
